Literature DB >> 20493827

Reduction of intersectin1-s induced apoptosis of human glioblastoma cells.

Yongjie Ma1, Bingbing Wang, Wenliang Li, Guoguang Ying, Li Fu, Ruifang Niu, Feng Gu.   

Abstract

Malignant gliomas have a high proliferation ability and high tendency to invade diffusely into surrounding healthy brain tissues, thereby precluding their successful surgical removal. Intersectin1 (also called ITSN1) as a molecular linker in the central nervous system is well known as an important regulator of endocytosis and exocytosis. ITSN1 has two isoforms: ITSN1-l and ITSN1-s. In this study, we show that siRNA-mediated down regulation of ITSN1-s induced glioma cells apoptosis. In addition, we demonstrate the possible mechanisms by which ITSN1-s functions in glioma cells apoptosis. Our data demonstrate that several key proteins, including FAK, Akt, Bcl-2, BAD which are critical for cells apoptosis were probably involved in ITSN1-s signaling pathways. Our results indicate that ITSN1-s is an effecter in regulation of gliomas cells apoptosis, and identify that ITSN1-s may be a new potentially anti-apoptosis target for therapeutic of gliomas. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493827     DOI: 10.1016/j.brainres.2010.05.028

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme.

Authors:  Yong Yan; Lei Zhang; Ying Jiang; Tao Xu; Qiyong Mei; Hongxiang Wang; Rong Qin; Yongxiang Zou; Guohan Hu; Juxiang Chen; Yicheng Lu
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-07       Impact factor: 4.553

2.  Altered Expression of Intersectin1-L in Patients with Refractory Epilepsy and in Experimental Epileptic Rats.

Authors:  Xiaoyan Yang; Xin Xu; Yujiao Zhang; Shasha Wang; Minghui Li; Xuefeng Wang
Journal:  Cell Mol Neurobiol       Date:  2015-03-18       Impact factor: 5.046

3.  Intersectin 1 is required for neuroblastoma tumorigenesis.

Authors:  A Russo; J P O'Bryan
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 4.  Intersectin-1s deficiency in pulmonary pathogenesis.

Authors:  Niranjan Jeganathan; Dan Predescu; Sanda Predescu
Journal:  Respir Res       Date:  2017-09-06

5.  Tracing the dynamics of gene transcripts after organismal death.

Authors:  Alex E Pozhitkov; Rafik Neme; Tomislav Domazet-Lošo; Brian G Leroux; Shivani Soni; Diethard Tautz; Peter A Noble
Journal:  Open Biol       Date:  2017-01       Impact factor: 6.411

6.  Alternative splicing-derived intersectin1-L and intersectin1-S exert opposite function in glioma progression.

Authors:  Ying Shao; Wei Chong; Xiaoli Liu; Yun Xu; Huikun Zhang; Qiao Xu; Zhifang Guo; Yawen Zhao; Ming Zhang; Yongjie Ma; Feng Gu
Journal:  Cell Death Dis       Date:  2019-06-03       Impact factor: 8.469

7.  Intersectin 1 (ITSN1) identified by comprehensive bioinformatic analysis and experimental validation as a key candidate biological target in breast cancer.

Authors:  Chen Xie; Wenmin Xiong; Junyu Li; Xia Wang; Chen Xu; Liping Yang
Journal:  Onco Targets Ther       Date:  2019-08-30       Impact factor: 4.147

Review 8.  Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways.

Authors:  Michael P Hunter; Angela Russo; John P O'Bryan
Journal:  Int J Mol Sci       Date:  2013-04-10       Impact factor: 5.923

9.  Intermittent hypothermia is neuroprotective in an in vitro model of ischemic stroke.

Authors:  Sui-yi Xu; Ya-fang Hu; Wei-pin Li; Yong-ming Wu; Zhong Ji; Sheng-nan Wang; Ke Li; Su-yue Pan
Journal:  Int J Biol Sci       Date:  2014-07-29       Impact factor: 6.580

10.  Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis.

Authors:  Niranjan Jeganathan; Dan Predescu; Jin Zhang; Fei Sha; Cristina Bardita; Monal Patel; Stephen Wood; Jeffrey A Borgia; Robert A Balk; Sanda Predescu
Journal:  Mol Cancer       Date:  2016-09-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.